ProStocks Logo
Unlimited Trades ₹899 Monthly
www.ProStocks.com
Contact us

Beta Drugs IPO vs D.P.Abhushan IPO

Comparison between Beta Drugs IPO and D.P.Abhushan IPO.

IPO Details

Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while D.P.Abhushan IPO is a SME Fixed Price proposed to list at NSE SME.

 Beta Drugs IPOD.P.Abhushan IPO
LogoBeta Drugs IPO LogoD.P.Abhushan IPO Logo
Issue CategorySMESME
Issue TypeIPOIPO
Process TypeFixed PriceFixed Price
Listing AtNSE SMENSE SME
Lead ManagersPantomath Capital Advisors Pvt.Ltd.Hem Securities Ltd.
RegistrarMUFG Intime India Pvt.Ltd.Bigshare Services Pvt.Ltd.
Market MakerPantomath Stock Brokers Pvt.Ltd.Hem Finlease Pvt.Ltd.
DRHPDRHP DRHP
RHPRHP RHP
Final ProspectusFinal Prospectus Final Prospectus
IPO Allotment URLIPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the D.P.Abhushan IPO is up to ₹15.77 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of D.P.Abhushan IPO is ₹28.00 per share.

 Beta Drugs IPOD.P.Abhushan IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹85.00 per share₹28.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares4000 shares
Fresh Issue Size21,66,400 shares56,32,000 shares
Fresh Issue Size (Amount)up to ₹18.41 Crup to ₹15.77 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total21,66,400 shares56,32,000 shares
Issue Size Total (Amount)up to ₹18.41 Crup to ₹15.77 Cr

IPO Timetable

Beta Drugs IPO opens on Sep 29, 2017, while D.P.Abhushan IPO opens on Oct 09, 2017. The closing date of Beta Drugs IPO and D.P.Abhushan IPO is Oct 04, 2017, and Oct 11, 2017, respectively.

 Beta Drugs IPOD.P.Abhushan IPO
Issue OpenSep 29, 2017Oct 09, 2017
Issue CloseOct 04, 2017Oct 11, 2017
Basis Of Allotment (Tentative)Oct 10, 2017Oct 16, 2017
Listing date (Tentative)Oct 12, 2017Oct 23, 2017

Financials & KPIs

Beta Drugs IPO P/E ratio is , as compared to D.P.Abhushan IPO P/E ratio of .

 Beta Drugs IPOD.P.Abhushan IPO
Financials

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets24.5415.208.01
Total Income41.6826.390.26
Profit After Tax5.181.130.11
NET Worth7.382.201.07
Reserves and Surplus6.371.190.06
Total Borrowing7.527.754.37
Amount in ₹ Crore

Company Financials (Restated)

Period Ended01 May 201731 Mar 201731 Mar 201631 Mar 2015
Assets146.19138.45144.80115.80
Total Income75.90453.71488.22459.89
Profit After Tax0.804.883.251.31
NET Worth22.2421.4316.9216.13
Total Borrowing98.5793.5194.1774.64
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)93.78%100%
Promoter Shareholding (Post-Issue)68.89%73.35%
Market Cap₹73.52 Cr.₹62.31 Cr.

Shares Offered

In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in D.P.Abhushan IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Beta Drugs IPO and 0 shares in D.P.Abhushan IPO.

 Beta Drugs IPOD.P.Abhushan IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation1,29,600 shares3,00,000 shares
QIB0 shares0 shares
NII10,83,200 shares28,16,000 shares
RII10,83,200 shares28,16,000 shares
Employee0 shares0 shares
Total21,66,400 shares56,32,000 shares

Bids Received (Subscription)

Beta Drugs IPO subscribed 18.97x in total, whereas D.P.Abhushan IPO subscribed 41.60x.

 Beta Drugs IPOD.P.Abhushan IPO
NII (times)29.93x67.95x
RII (times)8.00x15.24x
Total (times)18.97x41.60x

Compare with others

Beta Drugs IPOD.P.Abhushan IPO
Kaarya Facilities IPOPulz Electronics IPO
D.P.Abhushan IPOANI Integrated IPO
Omfurn India IPOSecUR Credentials IPO
IRIS Business Services IPOSheetal Cool Products IPO
CMM Infraprojects IPOKaarya Facilities IPO
Shreeji Translogistics IPOOmfurn India IPO
Milton Industries IPOIRIS Business Services IPO
Siddharth Education IPOCMM Infraprojects IPO
Shree Ganesh Remedies IPOBeta Drugs IPO
Tirupati Forge IPOShreeji Translogistics IPO

Compare:

Beta Drugs IPO Vs D.P.Abhushan IPO